EurekaMag
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Saccharomyces boulardii fungemia caused by treatment with a probioticum


Saccharomyces boulardii fungemia caused by treatment with a probioticum



Bmj Case Reports 2012



ISSN/ISBN: 1757-790X

PMID: 22605806

Saccharomyces cerevisiae, known as baker's yeast, is normally considered a non-pathogenic yeast. A genetically very similar subtype, S boulardii, is used in a probioticum (Sacchaflor) to prevent antibiotic-associated diarrhoea and in the treatment of recurrent Clostridium difficile associated diarrhoea. The authors present a case report of a 79-year-old woman with rheumatoid arthritis, who after a bowel resection developed S boulardii fungemia. Her postoperative course was complicated by nutritional problems, anaemia and several nosocomial infections including recurrent C difficile associated diarrhoea. The diarrhoea was treated with metronidazole, vancomycin and Sacchaflor. After 13 days of treatment, the patient developed fungemia with S boulardii. Treatment with Sacchaflor was immediately discontinued and the patient was successfully treated with amphotericin B. Fungemia is a rare, but a serious complication to treatment with probiotics. Accordingly, the authors find it important to remind the clinicians of this risk when prescribing probiotics especially to immunocompromised patients.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055639133

Download citation: RISBibTeXText

Related references

Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum. International Journal of Immunopathology and Pharmacology 27(1): 143-146, 2014

Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a non-immunocompromised host. Intensive Care Medicine 26(6): 825, 2000

Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. Journal of Clinical Gastroenterology 36(1): 41-43, 2003

Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii. American Journal of Medicine 105(1): 71-72, 1998

Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature. Medical Mycology Case Reports 15: 33-35, 2017

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment. Medical Mycology Case Reports 18: 15-17, 2017

Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient. Revista Argentina de Microbiologia 52(1): 27-30, 2020

Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities. Deutsche Medizinische Wochenschrift 128(48): 2531-2533, 2003

Saccharomyces cerevisiae fungemia in an immunocompromised patient not treated with Saccharomyces boulardii preparation. Journal of Infection 54(3): 310-311, 2007

Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 40(11): 1635-1637, 2005

Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 28(4): 930, 2000

Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 8(6): 504-505, 2000

Saccharomyces boulardii fungemia. Apropos of a case. Therapie 46(6): 498-499, 1991

Possible role of catheters in Saccharomyces boulardii fungemia. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 19(1): 16-20, 2000

Saccharomyces boulardii fungemia in a patient with severe burns. Annales Francaises d'Anesthesie et de Reanimation 14(4): 356-358, 1995